drugset / Trial / NCT00648778
Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan loxapine succinate 25 mg capsules to Watson Loxitane 25 mg capsules following a single, oral 25 mg (1 x 25 mg) dose administration under fasting conditions.
Timeline
- Start
- 2003-01
- Primary completion
- 2003-02
- Completion
- 2003-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | loxapine | Small molecule | 25 mg | Oral |
Indications
No indication recorded.